Development Level

Tbio 18 | 11,445
Tdark 3 | 6,588
Tchem 1 | 1,598

IMPC Phenotype

decreased hemoglobin content 1 | 68
increased erythrocyte cell num... 1 | 39
increased hematocrit 1 | 46
increased total body fat amoun... 1 | 134
preweaning lethality, incomple... 1 | 499
short tibia 1 | 97

Disease

Carcinoma 18 | 11,493
glioblastoma 13 | 5,792
atypical teratoid / rhabdoid tumor 11 | 5,112
group 3 medulloblastoma 11 | 4,104
medulloblastoma, large-cell 11 | 6,241
osteosarcoma 11 | 7,950
Astrocytoma, Pilocytic 10 | 3,081
adult high grade glioma 10 | 3,801
ependymoma 10 | 4,679
psoriasis 10 | 6,694
oligodendroglioma 9 | 2,850
ovarian cancer 9 | 8,520
astrocytic glioma 8 | 2,597
lung carcinoma 7 | 2,843
Pick disease 6 | 1,894
interstitial cystitis 6 | 2,312
pituitary cancer 6 | 1,972
primitive neuroectodermal tumor 6 | 3,035
subependymal giant cell astrocytoma 6 | 2,287
Breast cancer 5 | 3,578
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,291
pancreatic cancer 5 | 2,398
invasive ductal carcinoma 4 | 2,951
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
Griscelli syndrome 3 | 24
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,989
malignant mesothelioma 3 | 3,232
non-small cell lung cancer 3 | 2,890
Botulism 2 | 24
Kidney cancer 2 | 2,613
active ulcerative colitis 2 | 764
adrenocortical carcinoma 2 | 1,428
astrocytoma 2 | 1,146
cutaneous lupus erythematosus 2 | 1,057
ductal carcinoma in situ 2 | 1,745
group 4 medulloblastoma 2 | 1,855
lung adenocarcinoma 2 | 2,716
lung cancer 2 | 4,740
nasopharyngeal carcinoma 2 | 1,058
pediatric high grade glioma 2 | 1,064
primary pancreatic ductal adenocarcinoma 2 | 1,109
spina bifida 2 | 1,074
tuberculosis 2 | 2,010
Alzheimer's disease 1 | 658
Arrhythmogenic right ventricular cardiomyopathy 1 | 30
Attention deficit hyperactivity disorder 1 | 278
Autosomal recessive limb-girdle muscular dystrophy type 2B 1 | 5
Bladder exstrophy 1 | 32
Branchiootic syndrome 1 | 12
Chediak-Higashi syndrome 1 | 26
Chronic Lymphocytic Leukemia 1 | 262
Chronic obstructive pulmonary disease 1 | 184
Cocaine-Related Disorders 1 | 92
Cognitive disorder 1 | 50
Congenital Myasthenic Syndromes, Presynaptic 1 | 8
Congenital myasthenic syndrome 1 | 25
Cri-Du-Chat syndrome 1 | 16
Disease of anatomical entity 1 | 32
Disease of mental health 1 | 36
Distal muscular dystrophy 1 | 8
Down syndrome 1 | 499
Epilepsy 1 | 792
Exophthalmos 1 | 112
Hemolytic anemia 1 | 77
Intellectual disability 1 | 1,016
Lambert-Eaton myasthenic syndrome 1 | 12
Liddle syndrome 1 | 14
Liver Cirrhosis, Experimental 1 | 769
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC 1 | 1
Melanoma 1 | 711
Microcephaly 1 | 166
Multiple myeloma 1 | 1,332
Myasthenic Syndromes, Congenital 1 | 16
Neurodegenerative disease 1 | 414
Oppositional defiant disorder 1 | 17
Ornithine carbamoyltransferase deficiency 1 | 12
Osmotic diarrhea 1 | 3
Osteoporosis 1 | 363
Parkinson's disease 1 | 392
Pervasive developmental disorder 1 | 9
Polycystic ovary syndrome 1 | 360
Rickets 1 | 49
Schnyder Corneal Dystrophy 1 | 23
Skin cancer 1 | 469
Type 2 diabetes mellitus 1 | 272
active Crohn's disease 1 | 922
acute myeloid leukemia 1 | 783
aldosterone-producing adenoma 1 | 665
atypical teratoid/rhabdoid tumor 1 | 357
breast carcinoma 1 | 1,638
fibroadenoma 1 | 559
glioblastoma multiforme 1 | 142
head and neck cancer 1 | 271
head and neck cancer and chronic obstructive pulmonary disease 1 | 239
inflammatory breast cancer 1 | 286
maturity-onset diabetes of the young 1 | 32
medulloblastoma 1 | 720
pancreatic carcinoma 1 | 562
permanent neonatal diabetes mellitus 1 | 9

Tissue

Digestive Tract 21 | 17,369
Endocrine System 21 | 18,159
Female tissues 21 | 17,400
Liver and Pancreas 21 | 16,750
Male tissues 21 | 17,142
Urinary Tract 21 | 16,678
Nervous System 20 | 16,725
Skin and soft tissues 20 | 17,230
Respiratory system 19 | 16,393
Blood and immune system 17 | 16,909
Cardiovascular System 15 | 15,192

Target Family

Non-IDG 20 | 12,091
Epigenetic 1 | 242
Ion Channel 1 | 344

GO Process

regulation of calcium ion-depe... 22 | 22
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Synaptotagmin-15 SYT15 Tdark Non-IDG -0.22617 1.25 9
Synaptotagmin-2 SYT2 Tbio Non-IDG -1.93503 86.7 222
Rab effector Noc2 RPH3AL Tbio Non-IDG -1.26757 23.0 148
Synaptotagmin-7 SYT7 Tbio Non-IDG -1.75931 60.3 170
Synaptotagmin-like protein 3 SYTL3 Tbio Non-IDG -1.02669 10.4 84
Synaptotagmin-8 SYT8 Tbio Non-IDG -0.75787 4.64 73
Synaptotagmin-like protein 4 SYTL4 Tbio Non-IDG -1.22383 18.7 112
Double C2-like domain-containing protein beta DOC2B Tbio Non-IDG -1.19584 17.5 0
Transient receptor potential cation channel subfamily V member 6 TRPV6 Tchem Ion Channel -2.38299 247.1 126
Synaptotagmin-10 SYT10 Tbio Non-IDG -0.86150 6.37 115